Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.Zacks Premium also includes the Zacks Style Scores. What are the Zacks Style Scores? The Zacks Style Sc ...

Market Overview - As the first quarter of 2025 concluded, initial market optimism faded due to trade war fears and economic uncertainty [1] - No S&P 500 sector achieved double-digit gains, with energy leading at an 8.08% rise [2] Top Performers - CVS Health emerged as the top-performing S&P 500 stock, surging 52.8% following stronger-than-expected fourth-quarter earnings [3] - Philip Morris International followed with a 33.1% gain, driven by growth in its smoke-free product segment and high dividend appeal [5] - Newmont Corporation rose 30.5% due to increasing gold prices amid market uncertainty [6] - AT&T Inc. gained nearly 26%, benefiting from its domestic business model that insulated it from tariff volatility [7] Financial Highlights - CVS Health exceeded Wall Street estimates on revenue and adjusted earnings per share, trading at $66.79 [4] - Philip Morris International offers a quarterly dividend of $1.35 per share, with shares trading at $161.75 [5] - Newmont Corporation's stock is trading at $47.60 [6] - AT&T's stock is currently at $28.73, favored by income-focused investors due to its strong dividend yield [7]

There's no ignoring it. President Trump's tariffs and trade threats are roiling the markets, sending the S&P 500 into a correction for the first time since 2022. The tariffs announced today were just the latest move fueling investor uncertainty.Meanwhile, consumer sentiment is rapidly falling, and businesses are increasingly fearful as the manufacturing sector just fell into a contraction, according to the March ISM survey. Much of the economy is at risk from tariffs and the impact of a weakening economy. F ...

Group 1: Market Overview - The end of Q1 2025 is approaching, with many S&P 500 stocks showing strong year-to-date performances despite recent volatility from tariff discussions and economic developments [1] - Notable top performers include Philip Morris (PM), CVS Health (CVS), and Newmont (NEM) [1] Group 2: Philip Morris (PM) - Philip Morris has reported better-than-expected results, with EPS growing by 14% and sales increasing by 7% [2] - Smoke-free products exceeded 40 billion units for the first time in FY24, with net revenues for the Smoke-free Business (SFB) rising by 14.2% and gross profit increasing by 18.7% [3] - The company offers a high dividend yield of 3.5% annually and is recognized as a Dividend King [3] Group 3: CVS Health (CVS) - CVS shares have rebounded significantly in 2025, up 50% year-to-date, ending a prolonged decline [5] - The company experienced a 4% year-over-year sales increase, although EPS declined by 44% [5] - Analysts are optimistic about upcoming quarterly results, with a consensus EPS estimate of $1.62 per share, reflecting a 12% increase and 23% year-over-year growth [7] Group 4: Newmont (NEM) - Newmont, a major gold producer, has seen its stock rise nearly 30% year-to-date, driven by a surge in gold prices [8] - The average gold price per ounce reached $2,643, up from $2,004 in the same period last year [9] - The company reported a record free cash flow of $1.6 billion, enhancing its ability to pay dividends and reduce debt [9][13]

Core Insights - Investing in "sin stocks," which include companies in alcohol, tobacco, and gambling, has historically provided attractive returns despite ethical concerns due to strong cash flows and loyal customer bases [1][7] Industry Overview - Sin stocks tend to perform well in both economic booms and downturns, benefiting from stable demand, strong pricing power, and consistent dividend payouts [2] - The U.S. alcoholic beverages market is projected to grow from $543.13 billion in 2024 to $806.44 billion by 2033, with a CAGR of 4.99% [4] - The global tobacco market is expected to grow from $899.9 billion in 2024 to $1,157.8 billion by 2032, achieving a CAGR of 3.2% from 2025 to 2032 [5] - The North America online gambling market was valued at $16.56 billion in 2024 and is projected to expand at a CAGR of 12.2% from 2025 to 2030 [6] Company Highlights - Altria Group (MO) dominates the tobacco industry with strong dividends due to its market presence and pricing strategy [3] - Las Vegas Sands (LVS) is positioned as a leader in the gambling sector, benefiting from the acceleration of sports betting legalization and online gaming expansion [3] - Molson Coors Beverage Company (TAP) is transforming its business to align with evolving consumer preferences, focusing on premiumization and innovation [9][10] - Wynn Resorts (WYNN) is enhancing its luxury hospitality offerings and expanding into high-growth markets, including a significant project in the UAE [12][13] - Philip Morris International Inc. (PM) is leading the industry toward a smoke-free future by expanding its smoke-free product portfolio and maintaining strong financial performance [15][16]

Perhaps not surprisingly, defensive stock Philip Morris International ( PM ) has been one of the best-performing US companies this year. When I initially covered the stock in November 2024, I argued that it was a best-in-class defensive stock with strongI am an investment professional with a background in both equity and real estate markets. I specialize in identifying long-only opportunities that offer safe and growing dividends, aiming to outperform the broader market on a risk-adjusted return basis. In a ...

Core Insights - Philip Morris International (NYSE: PM) has experienced a significant increase of 66% over the past year, outperforming NVIDIA's (NVDA) 12-month returns amidst a broader market trend [1]. Company Performance - The stock performance of Philip Morris International has been notably strong, with a 66% rise in value over the last year, indicating robust investor interest and confidence in the company's future prospects [1]. Market Context - The current market environment shows a shift in investor focus, with analysts primarily concentrating on AI technologies, yet Philip Morris is achieving substantial returns that surpass those of major tech companies like NVIDIA [1].

Core Viewpoint - The article compares Altria and Philip Morris International, highlighting their differing business models, financial performance, and growth prospects in the tobacco industry, particularly in the context of their transitions to smoke-free products. Business Model Comparison - Altria and Philip Morris, despite sharing cigarette brands, have different business models, with Altria focusing on the U.S. market and Philip Morris on international markets [2][3] - Philip Morris has successfully developed next-generation products like Iqos and Zyn, gaining significant market share, while Altria has struggled with its investments in Juul and cannabis [4][5][6] Financial Performance - In 2024, Altria's revenue declined by 1.9% to $24 billion, primarily due to a 10.2% drop in cigarette shipment volume, although it maintained a high adjusted operating margin of 61.2% [8][9] - Philip Morris reported a 7.7% increase in revenue to $37.9 billion, with a 0.6% rise in international cigarette volume and a 16% increase in operating income [9] Dividend and Valuation - Altria offers a dividend yield of 7% and trades at a price-to-earnings ratio of 11.3, maintaining a strong reputation as a dividend payer [10][11] - Philip Morris has a lower dividend yield of 3.5% but a higher P/E ratio of 22, reflecting its faster growth and success in next-gen products [11] Growth Prospects - Altria is beginning to see growth from its investment in Njoy, but it continues to face revenue losses and challenges in its core cigarette business [12] - Philip Morris is experiencing growth in both its next-gen products and its cigarette business, indicating a more favorable long-term growth trajectory [12][13]

Market Overview - The stock market began 2025 strong but has recently faced challenges due to trade wars and tariffs, with the S&P 500 down nearly 4.5% year to date [1] CVS Health - CVS Health has seen a significant increase of approximately 51% in 2025, boosted by better-than-expected year-end earnings and guidance in line with Wall Street expectations [3][4] - The company had a difficult previous year, with shares dropping by 43%, leading to a change in CEO, which has contributed to improved investor sentiment [4][5] - Despite the positive performance, CVS faces high medical costs and uncertainty in the healthcare sector, with a current valuation of 18 times trailing earnings, indicating it is not overly expensive [5][6] Super Micro Computer - Super Micro Computer's stock has risen by 26.5% in 2025, recovering from previous concerns about its financial statements and auditor issues [7][8] - The company successfully filed its financial statements on time with a new auditor, alleviating fears of delisting, and is benefiting from increased demand for IT infrastructure driven by AI developments [8] - However, the company reported a gross profit of $2.1 billion on sales of $14.9 billion, indicating thin margins, and potential risks from economic conditions and tariffs [9] Philip Morris International - Philip Morris International's shares increased by 27.9% in 2025, following better-than-expected guidance for adjusted earnings per share [10] - The stock received a boost from regulatory approval to market its nicotine pouch, Zyn, in the U.S., although concerns remain about the health implications of such products [11][12] - Despite the positive start to the year, the stock trades at 25 times earnings, raising questions about its long-term viability in a declining tobacco market [12]

Economic Outlook - The U.S. economy is showing signs of potential recession, with the Atlanta Federal Reserve predicting a 2.1% decline in Q1 GDP after earlier forecasts of over 2% growth [1] Walmart - Walmart is positioned as a top defensive stock, having gained 2% during the Covid recession while the S&P 500 lost 25%, and rose 12% during the Great Recession of 2008-2009 [2][3] - The company benefits from its size and scale, providing significant buying power that allows it to be a price leader during economic downturns [4] - Walmart's extensive reach means 90% of the U.S. population lives within 10 miles of a store, which supports its Walmart+ membership growth, particularly among wealthier consumers [5] - Upper-income households, defined as those earning $100,000 or more, have been a key growth driver for Walmart, potentially increasing their patronage during a recession [6] - Walmart is also expanding its advertising and online marketplace businesses, enhancing fulfillment capabilities for third-party merchants [7] Philip Morris International - Philip Morris International's traditional cigarette business remains strong, with modest volume growth and strong pricing power, particularly in international markets [8] - The company's smokeless products, such as Zyn and IQOS, are significant growth drivers, with Zyn projected to see volume growth of 34% to 41% this year [9] - IQOS has also experienced solid growth, with plans for broader rollout in the U.S. pending FDA approval [10] - Zyn and IQOS offer better unit economics compared to traditional cigarettes, with Zyn's contribution level being six times greater and IQOS's twice as good [11] - The addictive nature of Philip Morris' products makes them resilient during economic downturns, and the company offers a 3.5% dividend yield, making it an attractive growth stock in a defensive industry [12]